BVMF/I1SR34 (BVMF/I1SR34)

Brazil Stock Exchange: BVMF/I1SR34 · BRL

R$119

-0.74 (-0.6%)· Recorded snapshot

Market cap	827.3B
Revenue (ttm)	60B
Net income (ttm)	15.3B
EPS (ttm)	R$2.21
P/E (trailing)	53.7x
P/E (forward)	36.4x
Volume	1,673
Beta	1.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 60B
Net income (ttm): 15.3B
EPS (ttm): R$2.21
P/E (trailing): 53.7x
P/E (forward): 36.4x
Market cap: 827.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E36.4

P25 n/aP50 n/aP75 n/a

Trailing P/E53.7

P25 n/aP50 n/aP75 n/a

ROE17.9

P25 n/aP50 n/aP75 n/a

ROIC24

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/I1SR34 indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

USD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-20
Employees	17,021
Employees change	1,383
Employees growth	8.84%
Enterprise value	BRL 806.3B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1995
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	BRI1SRBDR001
Last earnings date	2026-10-20
Last refreshed	2026-10-29
Last stock split date	2022-11-21
Last stock split type	Forward
Market cap	BRL 827.3B
Next earnings date	2027-01-19
Price	BRL 118.91
Price currency	BRL
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	bvmf/I1SR34
Website	https://www.intuitive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	62.06x
Average P/E ratio (3Y)	66.16x
Average P/E ratio (5Y)	66.24x
Earnings yield	1.86%
EV/Earnings	52.64x
EV/EBIT	40.88x
EV/EBITDA	33.26x
EV/FCF	43.26x
EV/Sales	12.96x
FCF / EV yield	2.31%
FCF yield	2.25%
Forward P/E	36.43x
Graham number	24.38176
Graham upside	-79.5%
Lynch fair value	BRL 26.09
Lynch upside	-78.06%
P/(FCF - SBC) ratio	57.81x
P/(OCF - SBC) ratio	49.08x
P/B ratio	9.91x
P/E ratio	53.74x
P/FCF ratio	44.39x
P/OCF ratio	39.05x
P/S ratio	13.79x
Price / tangible book value	10.49x
Price/EBITDA ratio	35.72x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	31.7%
EBITDA margin	38.61%
Effective tax rate	17.85%
FCF margin	30.1%
Gross margin	66.64%
Operating margin	31.7%
Pretax margin	31.26%
Profit margin	25.54%
Profit per employee	BRL 899,947
Profitable quarters	35
Profitable years	22
Revenue per employee	BRL 3.5M
ROA	11.86%
ROA (5Y)	8.5%
ROCE	21.83%
ROE	17.93%
ROE (5Y)	14.94%
ROIC	23.97%
ROIC (5Y)	21.26%
SBC / revenue	7.21%
Tax / revenue	5.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.47%
EPS growth (Q)	-23.59%
EPS growth (QoQ)	-34.93%
EPS growth 10Y	14.92%
EPS growth 3Y	24.86%
EPS growth 5Y	12.27%
EPS growth years	3
FCF growth	58.41%
FCF growth (Q)	51.03%
FCF growth (QoQ)	17.14%
FCF growth 3Y	42.04%
FCF growth 5Y	13.81%
Gross profit growth	20.93%
Gross profit growth (Q)	23.71%
Gross profit growth 3Y	19.14%
Gross profit growth 5Y	15.26%
Net income growth	7.66%
Net income growth (Q)	-25.78%
Net income growth (QoQ)	-36.1%
Net income growth 3Y	24.93%
Net income growth 5Y	11.85%
Net income growth years	3
OCF growth	38.13%
OCF growth (Q)	45.55%
OCF growth (QoQ)	15.37%
OCF growth 10Y	14.67%
OCF growth 3Y	26.43%
OCF growth 5Y	13.73%
Operating income growth	30.34%
Operating income growth (Q)	33.58%
Operating income growth 3Y	28.81%
Operating income growth 5Y	15.49%
Revenue growth	20.45%
Revenue growth (Q)	21.7%
Revenue growth (QoQ)	5.41%
Revenue growth 10Y	16.02%
Revenue growth 3Y	19.11%
Revenue growth 5Y	16.1%
Revenue growth quarters	24
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -2.5B
Depreciation and amortization	BRL 4.3B
EBIT	BRL 19B
EBITDA	BRL 23.2B
EPS	BRL 2.21
Financing cash flow	BRL -24.2B
Free cash flow	BRL 18.6B
Free cash flow minus SBC	BRL 14.3B
Gross profit	BRL 40B
Income taxes	BRL 3.3B
Investing cash flow	BRL 3.9B
Net cash flow	BRL 895.6M
Net income	BRL 15.3B
Operating cash flow minus SBC	BRL 16.9B
Operating income	BRL 19B
Revenue	BRL 60B
Stock-based compensation	BRL 4.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	32.46
Book value per share	BRL 238.91
Debt / equity	0
Goodwill	BRL 3B
Long-term assets	BRL 55.1B
Long-term liabilities	BRL 3.2B
Net cash (debt)	BRL 20.9B
Net cash / market cap	2.53%
Net cash growth	-17.65%
Net debt / EBITDA	-0.9
Net debt / equity	-0.25
Net debt / FCF	-1.12
Piotroski F-Score	6
Property, plant and equipment	BRL 30.4B
Shareholders' equity	BRL 83.5B
Tangible book value	BRL 78.9B
Tangible book value per share	BRL 227.64
Total assets	BRL 100.2B
Total cash	BRL 20.9B
Total debt	BRL 0
Total liabilities	BRL 16.7B
WACC	12.3%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	BRL 45.1B
Current liabilities	BRL 13.5B
Current ratio	3.33
Inventory turnover	1.98
Net working capital	BRL 9.6B
Quick ratio	2.32
Working capital	BRL 30.5B
Working capital turnover	9.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.75%
Shareholder yield	1.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 106.91
1D price change	-0.62%
1M price change	13.81%
1M total return	13.81%
1W price change	8.26%
1W total return	8.26%
1Y price change	-19.07%
1Y return CAGR	-19.08%
1Y total return	-19.07%
20-day SMA	BRL 108.61
200-day SMA	BRL 114.08
3M price change	27.97%
3M total return	27.97%
3Y price change	84.5%
3Y return CAGR	22.64%
3Y total return	84.5%
50-day SMA	BRL 102.50
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 162.55
52-week high date	2026-01-07
52-week low	BRL 83.81
52-week low date	2026-07-23
5Y price change	25.55%
5Y return CAGR	4.66%
5Y total return	25.55%
6M price change	1.32%
6M total return	1.32%
All-time high	BRL 184.00
All-time high date	2025-01-23
All-time low	BRL 39.21
All-time low date	2020-03-25
Average true range (ATR)	BRL 3.30
Average volume	2.1K
Beta (5Y)	1.46
Change from 52-week high	-26.85%
Change from 52-week low	41.88%
Change from all-time high	-35.38%
Change from all-time low	203.28%
Change from open	-0.51%
Day's gap	-0.11%
Dollar volume	BRL 198,936
High price	BRL 120.57
Low price	BRL 118.91
Monthly RSI	49.75
Open price	BRL 119.52
Position in 52-week range	0%
Previous close	BRL 119.65
Price vs 150-day SMA	11.23%
Price vs 20-day SMA	9.48%
Price vs 200-day SMA	4.24%
Price vs 50-day SMA	16.01%
Relative volume	0.81
RSI	70.58
Sharpe ratio	0.09
Sharpe ratio (3Y)	0.4
Sharpe ratio (5Y)	0.38
Sortino ratio	0.27
Sortino ratio (3Y)	0.77
Sortino ratio (5Y)	0.72
Volume	1.7K
Weekly RSI	58.32
YTD price change	-24.47%
YTD total return	-24.47%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	344.6M
Shares change (QoQ)	-1.6%
Shares change (YoY)	-1.75%
Shares held by insiders	0.48%
Shares held by institutions	90.08%
Short ratio	3 days

Deeper analysis on BVMF/I1SR34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/I1SR34 report

Is a complete BVMF/I1SR34 research report available?

No complete published report is available for bvmf/I1SR34 (BVMF/I1SR34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/I1SR34 (BVMF/I1SR34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/I1SR34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/I1SR34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/I1SR34

Frequently asked questions